Figure 1

![Figure 1: Adjusted response rates (defined as three-point improvement) are compared for THC and CBD across six common palliative care symptoms. The chart illustrates the relative contributions of each cannabinoid to patient-reported symptom relief.]()

> Source: David J Casarett et al. "Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Sy." *Journal of palliative medicine*, 2019. PMID: [31386592](https://pubmed.ncbi.nlm.nih.gov/31386592/)

<figure>
  <img src="" alt="Adjusted response rates (defined as three-point improvement) are compared for THC and CBD across six common palliative care symptoms. The chart illustrates the relative contributions of each cannabinoid to patient-reported symptom relief." />
  <figcaption>Figure 1. Adjusted response rates (defined as three-point improvement) are compared for THC and CBD across six common palliative care symptoms. The chart illustrates the relative contributions of each cannabinoid to patient-reported symptom relief.<br>  Source: David J Casarett et al. "Benefit of Tetrahydrocannabinol versus Cannabidiol for Common Palliative Care Sy." <em>Journal of palliative medicine</em>, 2019. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/31386592/">31386592</a></figcaption>
</figure>